Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
938.45Prev. Close
936.70Volume
6,67,543Total traded value
63.02 CrUpper Circuit
1,038.50Lower Circuit
849.70Fundamentals
| Market Cap | ₹94,968Cr |
| ROE | 19.44% |
| P/E Ratio(TTM) | 18.88 |
| EPS(TTM) | 49.98 |
| P/B Ratio | 3.75 |
| Dividend Yield | 1.17% |
| Industry P/E | 33.92 |
| Book Value | 251.45 |
| Debt to Equity | 0.38 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Zydus Lifesciences
Zydus Lifesciences is a global, innovation-driven company pioneering scientific research and creating healthcare solutions with patients at its core. Its core purpose is to empower people with the freedom to live healthier and more fulfilled lives through its life-changing work. Demonstrating its market strength, it is the 5th largest generic company in the United States based on prescriptions.;
| Parent Organisation | Zydus Lifesciences |
| Managing Director | Dr. Sharvil Patel |
| NSE Symbol | ZYDUSLIFE |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 38.74 | ||
| Cipla | NA (0.00%) | 22.36 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 17.53 | ||
| Mankind Pharma | NA (0.00%) | 52.66 |